The Role of Androgens in Normal and Malignant Breast Tissue.
Androgens, like estrogens, can be synthesized in the breast. As both active androgens and their corresponding receptors are present in breast tissue, we conclude that they play a role in breast physiology. This is supported by the fact that insufficient androgen production or sensitivity results in the development of gynecomastia. Complete androgen insensitivity due to receptor defects leads to normal female breast development in these XY women. While breast development is completely inhibited by male testosterone levels, partial but not total degradation of a developed breast by androgen treatment appears to be possible. Breast cancer in early stages seems to fulfill the prerequisites of androgen responsiveness. Androgen treatment of advanced breast cancer has shown similar effectiveness as anti-estrogen or estrogen-ablative therapy, but also considerable side effects. It has been speculated that the use of selective androgen modulators (SARMs), either alone or preferably in addition to anti-estrogens or aromatase inhibitors, may be a promising alternative to current therapy modalities in hormone-dependent breast cancer. In addition, future studies on the use of SARMs in prophylactic settings seem to be justified.
Tiefenbacher
Katharina
K
Department of Gynecology and Obstetrics, Medical University of Innsbruck, Austria.
Daxenbichler
Günter
G
FASEB J. 2003 Feb;17(2):274-6
12490543
J Steroid Biochem Mol Biol. 2002 May;81(1):65-8
12127043
Nucleic Acids Res. 1994 Aug 11;22(15):3181-6
8065934
Eur J Surg Oncol. 1987 Apr;13(2):113-7
3556591
Menopause. 2003 Jul-Aug;10(4):292-8
12851512
J Steroid Biochem Mol Biol. 1995 Jun;52(6):541-6
7779758
J Clin Endocrinol Metab. 1994 Aug;79(2):627-32
8045987
J Mol Endocrinol. 2001 Feb;26(1):11-9
11174850
Endocr Relat Cancer. 2005 Dec;12(4):1071-82
16322344
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2990-4
16365023
Breast Cancer Res. 2006;8(5):R54
16987421
Menopause. 2007 Mar-Apr;14(2):183-90
17108847
FASEB J. 2007 Aug;21(10):2285-93
17413000
FASEB J. 2000 Sep;14(12):1725-30
10973921
J Pathol. 1993 May;170(1):31-5
8100853
Mt Sinai J Med. 1988 Sep;55(4):309-12
3266300
Cancer Res. 1989 Jan 15;49(2):471-6
2521298
Gynecol Endocrinol. 2002 Apr;16(2):113-20
12012621
J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):281-6
9365202
J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):97-101
17624762
BMC Cancer. 2008 May 28;8:149
18507821
Hum Mutat. 2004 Jun;23(6):527-33
15146455
J Steroid Biochem Mol Biol. 2006 Oct;101(2-3):136-44
16930994
Cancer Res. 1985 Jun;45(6):2900-6
3986816
Eur J Cancer. 2007 Nov;43(16):2373-80
17728127
Br J Cancer. 1994 Mar;69(3):555-61
8123487
J Steroid Biochem. 1986 Jun;24(6):1117-25
3736038
Cancer. 1975 Aug;36(2):308-10
1098764
J Clin Endocrinol Metab. 1981 Jul;53(1):58-68
7195404
J Histochem Cytochem. 1991 Jul;39(7):927-36
1865110
Int J Cancer. 2007 Jan 15;120(2):285-91
17066438
Mol Endocrinol. 1999 Jan;13(1):66-81
9892013
Br J Cancer. 2005 Feb 14;92(3):547-52
15685233
Med Clin (Barc). 2005 Apr 23;124(15):598-9
15860181
Endocr Rev. 2003 Apr;24(2):152-82
12700178
Breast Cancer Res Treat. 1999 Sep;57(2):175-82
10598044
Folia Histochem Cytobiol. 2006;44(3):165-72
16977795
Endocr Rev. 2004 Jun;25(3):374-88
15180949
J Nutr. 2006 Nov;136(11):2754-9
17056796
J Clin Endocrinol Metab. 2005 Feb;90(2):893-903
15585562
Endocr Rev. 1995 Jun;16(3):271-321
7671849
Ann N Y Acad Sci. 1990;586:143-5
2356995
Nat Genet. 1992 Oct;2(2):132-4
1303262
J Steroid Biochem Mol Biol. 1996 Aug;58(5-6):557-61
8918982
Breast Cancer Res Treat. 1995 May;34(2):139-46
7647331
J Pathol. 1993 May;170(1):37-43
8326458
Endocrinology. 1999 Jan;140(1):416-21
9886853
Mol Cell Endocrinol. 2006 Mar 27;248(1-2):199-203
16414180
Hum Mol Genet. 1993 Nov;2(11):1799-802
8281139
Cancer Res. 2000 Feb 15;60(4):936-43
10706108
J Soc Gynecol Investig. 2000 Jul-Aug;7(4):257-65
10964026
Endocr Relat Cancer. 2008 Sep;15(3):665-92
18541621
Br J Cancer. 2000 Feb;82(3):518-23
10682658
Biochem Biophys Res Commun. 2000 Aug 28;275(2):488-92
10964692
J Steroid Biochem Mol Biol. 1995 May;52(5):459-67
7748811
J Clin Endocrinol Metab. 1996 Sep;81(9):3404-7
8784104
Am J Surg. 2006 May;191(5):576-80
16647340
J Clin Endocrinol Metab. 2007 Sep;92(9):3470-5
17579193
Endocr Rev. 2005 Apr;26(2):171-202
15561802
J Histochem Cytochem. 1994 Aug;42(8):1169-75
8027537
J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):293-7
10419005
Cell. 2005 Sep 9;122(5):751-62
16143106
Int J Cancer. 1992 Oct 21;52(4):581-4
1399140
Breast Care (Basel). 2008;3(3):183-189
20824037
Ann N Y Acad Sci. 2004 Dec;1038:14-43
15838095
J Steroid Biochem Mol Biol. 2000 Jan-Feb;72(1-2):23-7
10731634
Med Mol Morphol. 2007 Sep;40(3):121-7
17874044
Cell Tissue Res. 2003 Feb;311(2):217-26
12596041
Int J Cancer. 1997 Aug 7;72(4):574-80
9259393
J Clin Endocrinol Metab. 2002 Dec;87(12):5760-8
12466383
J Histochem Cytochem. 1993 May;41(5):671-8
8468448
J Histochem Cytochem. 2006 Aug;54(8):905-10
16618941
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):449-54
14623543
Mol Cell Endocrinol. 1997 Jun 20;130(1-2):43-51
9220020
J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):76-84
17596930
Virchows Arch. 2005 Oct;447(4):695-700
16075292
Mol Cell Endocrinol. 1991 Jul;78(3):C113-8
1838082
J Steroid Biochem Mol Biol. 2005 Jan;93(1):25-34
15748829
J Clin Endocrinol Metab. 2003 Aug;88(8):3467-73
12915619
Endocr Relat Cancer. 2008 Mar;15(1):113-24
18310280
Mol Endocrinol. 1989 Aug;3(8):1310-2
2779585
Int J Cancer. 2008 May 1;122(9):1931-40
18183589